 | | |
| Analysts
| Firm |
Analyst |
A.G. Edwards | Alex Hittle | Banc of America | Michael King | Bear Stearns | Alexandra Lee | Bernstein | Geoff Porges | Cathay Financial | Sena Lund | CIBC World Markets Corp. | Matthew Geller | CS First Boston | Mark Augustine | Deutsche Bank - North America | Dennis Harp | Goldman, Sachs & Company | May-Kin Ho | J.P. Morgan | David Molowa | Jefferies & Co. | Adam Walsh | Leerink Swann | William Tanner | Legg Mason | John Woolford | Lehman Brothers | Craig Parker | Merrill Lynch | Eric Ende | Morgan Stanley | Caroline Copithorne | Prudential Securities | John Sonnier | RBC Capital Markets | Jennifer Chao | Salomon Smith Barney | Elise Wang | SG Cowen Securities | Eric Schmidt | ThinkEquity Partners | Sapna Srivastava | U.S. Bancorp Piper Jaffray | Mark Schoenbaum | UBS Warburg | Meirav Chovav | Wachovia Securities | Martin Auster | William Blair | Winton Gibbons | WR Hambrecht | Jason Kantor |
|
Notice to Readers: Biogen is followed by the analysts listed above. These lists will change periodically as analysts start or terminate coverage of Biogen, and due to turnover, promotions and the like at the firms listed above. For this reason, these lists may not be complete. We are providing these lists as a service only and not as an endorsement or adoption of or agreement with any information, conclusions or recommendations of any of these analysts. Any opinions, forecasts or estimates regarding the performance of Biogen made by these analysts are theirs alone and do not represent the opinions, forecasts or estimates of Biogen or our management. We disclaim any responsibility for any information provided in analyst reports, including any inaccuracies they may contain. Some of these firms may be market-makers in Biogen’s stock and/or hold other long or short positions in the stock, and may provide services to Biogen for which they receive compensation from Biogen.
Biogen, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Biogen, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Biogen, Inc. or its management. Biogen, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. |
|
|
|
